DISEASE
MODELING

At MitoCare we also focus on the diagnostics and the pathogenesis of disorders driven by mitochondrial dysfunction.

MitoCare investigators study the consequences of mitochondrial dysfunction at the organismal level (in vivo) and in vitro models.
RRF_edited.png

Every 30 minutes a child is born who will develop a mitochondrial disease by age 10.

MITOCARE's
DISEASE MODELS

Hover here...

MURINE in vivo models
Chronic Alcoholic Rat
High Fat Diet Mouse

Friedreich's Ataxia
PiC Knock-Out
MICU1 Knock-Out
MICU2 Knock Out
Miro1 Knock Out
IP3r Knock-Out
EMRE/Smtd1 Knock-Out
ACOT2 Knock-Out
DRP1 Knock-Out 
PATIENT DERIVED IN VITRO modelS
Fibroblasts and Lymphoblasts
PiC Loss of Function
MICU1 and MICU2 Loss of Function
Autosomal Dominant Optic Atrophy OPA1 mutations
MSTO1 mutations
MERRF and MELAS Fibroblasts
"Common Deletion" Fibroblasts


AD HOC IN VITRO modelS
Using cutting-edge CRISPR Cas9 genetic engineering, MitoCare researchers create new relevant models every day.